APOA2 抗体 (FITC)
Quick Overview for APOA2 抗体 (FITC) (ABIN7454056)
抗原
See all APOA2 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
原理
- Goat anti-Human Apo AII [F04] Antibody FITC Conjugated
-
免疫原
- Human Apolipoprotein AII
-
亚型
- IgG
-
-
-
-
限制
- 仅限研究用
-
-
-
浓度
- 1 mg/mL
-
缓冲液
- 75 mM Sodium Phosphate, 75 mM NaCl, 0.5 mM EDTA, 0.02 % Sodium azide, pH 7.2
-
储存液
- Sodium azide
-
注意事项
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
储存条件
- 4 °C
-
有效期
- 12 months
-
-
- APOA2 (Apolipoprotein A-II (APOA2))
-
别名
- ApoAII
-
背景
- Background: Apo AII comprises 25 % of HDL. It exists in human plasma as a dimer of 2 identical chains of 77 amino acid residues, joined by disulfide. The molecular weight is reported to be 8.7 kDa for a single chain (Brewer et al., 1972).Studies on mouse reported that apo AII may be proatherogenic (Warden et al., 1993), however, case-control study in the large European Prospective Investigation demonstrated that plasma Apo AII concentrations were strongly inversely correlated with CHD events. (Birjmohun et al., 2007)
-
基因ID
- 336
-
NCBI登录号
- NP_001634
-
UniProt
- P02652
-
途径
- Regulation of Lipid Metabolism by PPARalpha, Production of Molecular Mediator of Immune Response, Negative Regulation of Transporter Activity, Lipid Metabolism
抗原
-